Karyopharm Therapeutics Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
Location
85 Wells Avenue, Second Floor, Newton, Massachusetts

Insiders trading volume in the past year

Karyopharm Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Paulson President and CEO, Director $2.54 M -$166 K -6.14% Jun 4, 2024
Sharon Shacham Chief Scientific Officer $1.37 M Mar 29, 2022
Michael Kauffman Director $1.32 M Feb 28, 2022
Sohanya Cheng EVP & Chief Commercial Officer $1.06 M -$41.6 K -3.77% Feb 29, 2024
Michael Mason EVP, CFO & Treasurer $873 K -$59.7 K -6.4% Jun 4, 2024
Stuart Poulton EVP, Chief Development Officer $861 K -$39.1 K -4.34% Feb 29, 2024
Reshma Rangwala EVP & Chief Medical Officer $821 K -$33.4 K -3.91% Apr 22, 2024
Michael Mano SVP, General Counsel&Secretary $728 K -$29.3 K -3.87% Feb 29, 2024
Ran Frenkel EVP, Chief Dev. Officer $138 K Feb 28, 2022
Jatin Shah EVP, Chief Medical Officer $106 K Feb 17, 2022
Stephen Mitchener SVP, Chief Business Officer $105 K Feb 28, 2023
Garen Bohlin Director $37 K +$50 K May 29, 2024
Deepika Pakianathan Director $0 -$1.67 M -100% Jun 5, 2024
Peter Honig Director May 24, 2023
Mansoor Raza Mirza Director May 29, 2024
Zhen Su Director May 29, 2024
Barry Greene Director May 29, 2024
Chen Schor Director May 29, 2024
Christy J. Oliger Director May 29, 2024
Mikael Dolsten Director May 21, 2021

Recent Insider Transactions by Companies or Individuals for Karyopharm Therapeutics Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership